Skip to main content

Table 1 Clinical and demographic characteristics of the study population

From: Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency

Variable PLWH (n = 643)
Age, years, median (IQR) 52 (46, 61)
Sex (male), n (%) 557 (87)
Scandinavian or other European origin, n (%) 562 (87)
BMI (kg/m2), median (IQR) 25 (23, 27)
 Underweight, BMI < 18.5, n (%) 13 (2)
 Normal weight, BMI 18.5-24.99, n (%) 319 (50)
 Overweight, BMI25-29.99, n (%) 234 (36)
 Obese, BMI ≥ 30, n (%) 77 (12)
Abdominal obesity, n (%) 372 (58)
Smoking status
 Current, n (%) 154 (24)
 Previous, n (%) 218 (34)
 Never, n (%) 266 (41)
Hypertension, yes, n (%) 317 (49)
Transmission mode
 MSM, n (%) 461 (72)
 Heterosexual, n (%) 140 (22)
 IDU, n (%) 5 (0.8)
 Other, n (%) 10 (1.6)
Current CD4+, cells/µL, median (IQR) 660 (515, 831)
 < 200 10 (1.6)
 200–349 25 (4)
 350–499 101 (16)
 ≥ 500 467 (73)
CD4+ nadir < 200, cells/µL, n (%) 252 (39)
CD4+/CD8+ ratio, median (IQR) 0.9 (0.6, 1.2)
Time since HIV diagnosis, years, median (IQR) 16 (9, 24)
History of AIDS (yes), n (%) 111 (17)
Time with ART treatment, years, median (IQR) 13 (7, 20)
Exposure to older generation ART, yes, n (%) 337 (52)
  1. Hypertension was defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg and/or antihypertensive treatment
  2. MSM: men who have sex with men; IDU: injecting drug use; ART: combined antiretroviral therapy